784 filings
Page 5 of 40
425
CRVO
CervoMed Inc
14 Aug 23
Business combination disclosure
4:16pm
8-K
CRVO
CervoMed Inc
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
3
Jill Davidson
11 Aug 23
Diffusion Pharmaceuticals / JILL DAVIDSON ownership change
8:16pm
425
CRVO
CervoMed Inc
9 Aug 23
Business combination disclosure
4:02pm
8-K
CRVO
CervoMed Inc
9 Aug 23
Other Events
4:02pm
10-Q
2023 Q2
CRVO
CervoMed Inc
Quarterly report
8 Aug 23
4:32pm
425
CRVO
CervoMed Inc
3 Aug 23
Business combination disclosure
4:15pm
8-K
CRVO
CervoMed Inc
3 Aug 23
Other Events
4:15pm
425
CRVO
CervoMed Inc
3 Aug 23
Business combination disclosure
8:33am
8-K
CRVO
CervoMed Inc
3 Aug 23
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
8:32am
425
CRVO
CervoMed Inc
31 Jul 23
Business combination disclosure
5:20pm
8-K
CRVO
CervoMed Inc
31 Jul 23
Entry into a Material Definitive Agreement
5:19pm
EFFECT
CRVO
CervoMed Inc
14 Jul 23
Notice of effectiveness
12:15am
424B3
CRVO
CervoMed Inc
13 Jul 23
Prospectus supplement
4:32pm
SEC STAFF
CRVO
CervoMed Inc
13 Jul 23
SEC staff action: Order
12:00am
CORRESP
CRVO
CervoMed Inc
12 Jul 23
Correspondence with SEC
12:00am
S-4/A
CRVO
CervoMed Inc
Registration of securities issued in business combination transactions (amended)
11 Jul 23
7:38pm
CORRESP
CRVO
CervoMed Inc
11 Jul 23
Correspondence with SEC
12:00am
4
Diana M Lanchoney
5 Jul 23
Diffusion Pharmaceuticals / DIANA M LANCHONEY ownership change
5:30pm
UPLOAD
CRVO
CervoMed Inc
5 Jul 23
Letter from SEC
12:00am